Ameritas Investment Partners, Inc. Procept Bio Robotics Corp Transaction History
Ameritas Investment Partners, Inc.
- $2.98 Billion
- Q4 2024
A detailed history of Ameritas Investment Partners, Inc. transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 4,661 shares of PRCT stock, worth $247,172. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,661
Previous 4,178
11.56%
Holding current value
$247,172
Previous $334,000
12.28%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding PRCT
# of Institutions
291Shares Held
40.1MCall Options Held
196KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA5.14MShares$273 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$185 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.75MShares$92.9 Million0.05% of portfolio
-
Loomis Sayles & CO L P1.21MShares$64 Million0.12% of portfolio
-
State Street Corp Boston, MA1.19MShares$63 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $2.36B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...